Evidence map›Paper›PMID 33525216›Full record

Observational studyActa bio-medica : Atenei Parmensis2020

Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate.

Giovanni Landoni, Alberto Zangrillo, Carolina Soledad Romero García, Carolina Faustini, Martina Di Piazza, Francesca Conte, Simone Gattarello, Artem Kuzovlev, Valery Likhvantsev, Riccardo Puglisi

Abstract readObservational Study
In one paragraph

Observational study in Acta bio-medica : Atenei Parmensis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giovanni LandoniDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute. Via Olgettina, 60, 20132, Milan, Italy. landoni.giovanni@hsr.it.
Alberto ZangrilloDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute. Via Olgettina, 60, 20132, Milan, Italy. zangrillo.alberto@hsr.it.
Carolina Soledad Romero GarcíaHospital General Universitario de Valencia. Avda Tres Cruces 2, 46014, Valencia, Spain. carolinasoledad.md@gmail.com.
Carolina FaustiniDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute. Via Olgettina, 60, 20132, Milan, Italy. carolina.faustini4@gmail.com.
Martina Di PiazzaDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute. Via Olgettina, 60, 20132, Milan, Italy. martina.dipiazza@yahoo.it.
Francesca ConteDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute. Via Olgettina, 60, 20132, Milan, Italy. francesca.conte1991@gmail.com.
Simone GattarelloDepartment of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute. Via Olgettina, 60, 20132, Milan, Italy. gattarello@gmail.com.
Artem KuzovlevFederal Research and Clinical Center of Resuscitation and Rehabilitation, Moscow, Russia. artem_kuzovlev@mail.ru.
Valery LikhvantsevV. Negovsky Reanimatology Research Institute, Petrovka str, 25, b.2, Moscow, Russia. lik0704@gmail.com.
Riccardo PuglisiDepartment of Social and Political Sciences, Università Degli Studi di Pavia, 27100, Pavia, Italy. riccardo.puglisi@unipv.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aim of the work The effect of tobacco smoking on COVID-19 disease is debated with common sense and experts suggesting a deleterious effect and manuscripts worldwide reporting a low prevalence of active tobacco smokers among intensive care unit patients. Methods We categorized countries worldwide into three groups with <25%; 25-45%; >45% of active male smokers with data expressed as median and interquartile range [IQR] and extracted data on SARS-CoV-2 infections and COVID-19 deaths per million inhabitants. We also applied multivariate regression techniques to adjust for several epidemiological factors. Results COVID-19 mortality was 13 (5-24) per million inhabitants in countries with male smokers >45% and 33 (4-133) in countries where male smokers were <25%. SARS-CoV-2 infection rates were 436 (217-954) and 1139 (302-4084) with data confirmed when dividing data for each continent and when controlling for confounding factors. Conclusions We found a counterintuitive low COVID-19 mortality and SARS-CoV-2 infection in countries with high prevalence of male smokers at the global level and within each continent, suggesting that active smoking habit is protective. Further research should urgently investigate which is the possible mechanism of action.

Indexed as

AgedCOVID-19Global HealthHumansMalePrevalenceTobacco Smoking

Identifiers

PMID33525216
PMCPMC7927473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.